Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1997
Medical Areas: Endocrinology

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Nutropin (somatropin-rDNA origin)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Genentech
Approval Status: Approved December 1997
Treatment Area: growth hormone deficiency

General Information

The liquid formulation of Nutropin (somatropin injection) has been approved for the replacement of endogenous growth hormone in adult patients with growth hormone deficiency. The product is currently indicated for pediatric growth hormone deficiency and chronic renal insufficiency.